Core Laboratories
CLB
186 hedge funds and large institutions have $855M invested in Core Laboratories in 2023 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 54 increasing their positions, 71 reducing their positions, and 19 closing their positions.
1,230% more call options, than puts
Call options by funds: $5.85M | Put options by funds: $440K
47% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 19
4% more funds holding
Funds holding: 178 → 186 (+8)
0.06% more ownership
Funds ownership: 103.64% → 103.7% (+0.06%)
24% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 71
26% less capital invested
Capital invested by funds: $1.16B → $855M (-$306M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$4.85M |
| 2 |
RA
Royce & Associates
New York
|
+$4.53M |
| 3 |
BlackRock
New York
|
+$4.46M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$2.83M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$2.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
-$10.2M |
| 2 |
FAM
Fred Alger Management
New York
|
-$6.18M |
| 3 |
SIC
Schwartz Investment Counsel
Plymouth,
Michigan
|
-$4.9M |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$3.32M |
| 5 |
VanEck Associates
New York
|
-$2.45M |
CLB Hedge Fund Activity: Q4 2023 in Review
186 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q4 2023, worth a combined $855M — down 26% from $1.16B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new CLB positions and 19 closed out — a net gain of 9 holders — while 54 added to existing stakes and 71 trimmed.
The largest buyer was Congress Asset Management, adding an estimated $4.85M. The largest seller was State Farm Mutual Automobile Insurance, exiting entirely with an estimated $10.2M sold.
- 186 institutional investors held Core Laboratories (CLB) as of Q4 2023, up from 178 in Q3 2023.
- Funds reported $855M of Core Laboratories stock for Q4 2023, down 26% quarter-over-quarter.
- 28 funds opened new Core Laboratories positions in Q4 2023 and 19 closed out, a net change of +9 holders.
- The largest Core Laboratories buyer in Q4 2023 was Congress Asset Management, an estimated $4.85M added.
- The largest Core Laboratories seller in Q4 2023 was State Farm Mutual Automobile Insurance, an estimated $10.2M sold.
Based on aggregated 13F filings for Q4 2023.